Actos Bladder Cancer Warning Added to Canadian Drug Label
Health Canada announced on April 19, 2012 that the country's warning labels would soon include Actos bladder cancer. The drug, which is prescribed to patients with type 2 diabetes, is allegedly linked to other serious risks, including Actos heart failure. The recent announcement, however, addresses only the risk of bladder cancer, which allegedly increases with higher dosages and/or long-term use of the medication. In the United States, Actos legislation has been consolidated into a federal MDL headquartered in Louisiana. In Canada, Actos lawsuits will be addressed by a country-wide class action suit.
Drug Side Effects is dedicated to bringing the latest news and information on personal injury lawsuits involving dangerous drugs, defective products and other lawsuits impacting the safety and well being of consumers in the US. We believe that people should be informed about dangerous products, serious side effects and breaking news on what's happening behind the scenes as lawsuits are initiated and adjudicated through the court system.
If there are topics that you would like to know more about, feel free to send us an email and we'll do our best to help add those subjects to our news schedule.